Here are six key notes on the device:
1. The Tritanium PL posterior lumbar case is constructed out of Stryker’s proprietary Tritanium technology and manufactured via a 3D additive manufacturing process. The Tritanium material is highly porous titanium designed for bone in-growth and biologic fixation.
2. The cage includes a variety of widths, lengths, heights and lordotic angles designed for several different patient anatomies.
3. The cage is intended for use in degenerative disc disease, grade 1 spondylolisthesis and degenerative scoliosis patients.
4. There are large lateral windows to allow fusion visualization in the cage on CT and X-ray.
5. The cage is intended for use with autograft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft inside the device and with supplemental spinal fixation systems cleared for the FDA for use in the lumbosacral spine.
6. The implants are available to the orthopedic and neurosurgeons in the second quarter of 2016.
More articles on orthopedic devices:
25 things to know about Zimmer-Biomet
Titanium vs. titanium-coated PEEK spinal implants: 4 key notes on impaction debris
InVivo Therapeutics adds Vidant Medical Center to INSPIRE study: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
